Late presentation for HIV remains a major health issue in Spain: Results from a multicenter cohort study, 2004–2018Marta Rava, Inmaculada Jarrín, Carmen Busca et al.|PLoS ONE|2021Cited by 48
Switching to bictegravir/emtricitabine/tenofovir alafenamide (BIC/FTC/TAF) plus darunavir/cobicistat in heavily antiretroviral-experienced, virologically suppressed HIV-infected adults receiving complex regimensDaniel Podzamczer, Antonio Rivero, Arkaitz Imaz et al.|Journal of Antimicrobial Chemotherapy|2023Cited by 10